Deutsche Bank’s Aegerion Pharmaceuticals AEGR Stock Holding History

Deutsche Bank’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-500	Closed	-$5K	–	5484
2015 Q4	$5K	Buy	+500	New	+$6.02K	﹤0.01%	5078

Deutsche Bank's AEGR Position: Q4 2016 in Review

Deutsche Bank sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 7,105 shares — an estimated $21K sold.

Deutsche Bank first reported a position in AEGR in Q2 2013 and held it in 14 quarters. The position peaked at $51.1M in Q3 2013. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Deutsche Bank reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Deutsche Bank sold 7,105 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $21K.
Deutsche Bank first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Deutsche Bank's Aegerion Pharmaceuticals position peaked at $51.1M in Q3 2013.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.